Local Health Unit Barcelos/Esposende, Public Health Unit
Phase
Not applicable
Started
2025-04-01
Last updated
2025-05-14
Condition(s) studied
Colon and Rectal Cancer
Investigational drug(s) / intervention(s)
Arm1: intervention 1 (SMS+call)Control group
Arm1: intervention 1 (SMS+call): The intervention will consist in two text messages (one and two weeks after received the screening test, respectively), an automated non-human call or a call made by the administrative assistant (three weeks after received the screening test), and a phone call made by a physician (four weeks after received the screening test)
Control group: The control group will not be subjected to any interventions to increase the adherence to screening.
Study summary
An experimental study through a randomized clinical trial, without blinding (for participants and the research team), with a control group (not subject to intervention) and an intervention group (subject to two text messages, an automated non-human call or a call made by the administrative assistant, and a phone call made by a physician).
Eligibility
Sex
ALL
Min age
49 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria:
Participants must be registered in the ULS of
Barcelos/Esposende and meet the following criteria:
1. Age between 50 and 74 years.
2. No symptoms such as weight loss in the last 6 months or gastrointestinal symptoms.
3. No prior diagnosis of CRC.
4. No diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease).
5. No family history of CRC in first- and second-degree relatives diagnosed before age 60.
6. No prior fecal occult blood test (FOBT) in the 11 months before receiving the collection kit or no prior sigmoidoscopy or colonoscopy in the last 24 months.
Exclusion Criteria:
1. Participants who did not receive the screening kit at home.
2. Participants without a phone number.
3. Participants who do not answer the phone or refuse to participate in the study.
4. Participants unable to consent or perform the screening due to physical, mental, or other conditions that seriously impair comprehension.
Primary outcome measure(s)
Adherence to colon and rectal screening [Time Frame: 6 weeks] — From April 2025 to June 2025 (6 weeks) Increase in adherence to colon and rectal screening
Proportion/cumulative proportion of patients who performed colon and rectal cancer screening among those who were invited to undergo it, after step 1 (SMS1), step 2 (SMS2), step 3 (administrative call) and step 4 (medical doctor call)
Trial sites (1)
Facility
City
Region
Status
Public Health Unit Barcelos/Esposende
Porto
Portugal
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
